Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Publication/Presentation Date
6-2024
Published In/Presented At
DOI: 10.47991/2835-9496/AJCMR-138
Disciplines
Medicine and Health Sciences
Department(s)
Fellows and Residents
Document Type
Article
COinS